{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:22:57Z","timestamp":1762273377696,"version":"3.41.2"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>This study examines the relationship between tumor burden score (TBS) and survival and recurrence following radical resection of hepatocellular carcinoma through a cohort study conducted in the Guangxi population of China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cohort study eventually recruited 576 HCC patients undergoing radical resection of HCC in the People\u2019s Hospital of Guangxi Zhuang Autonomous Region during 2013\u20132022. After determining the best threshold TBS, all cases were grouped to evaluate the relationship between TBS versus overall survival (OS) and cumulative recurrence. Using X-Tile software, the best threshold TBS to judge patient prognostic outcome following radical resection of HCC was 10.77.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Kaplan\u2013Meier curve analysis revealed that patients with high TBS showed considerably decreased OS relative to the control group, accompanied by an increased recurrence rate. According to multivariate Cox proportional regression, the patients with high TBS were associated with poorer OS (HR = 2.56, 95% CI 1.64\u20133.99, <jats:italic>P<\/jats:italic> &amp;lt; 0.001) and recurrence-free survival (RFS) (HR = 1.55, 95% CI 1.02\u20132.35, <jats:italic>P<\/jats:italic> &amp;lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In patients undergoing radical resection for HCC, higher TBS was significantly related to shorter OS and RFS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1359017","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T05:10:21Z","timestamp":1730437821000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of tumor burden score on prognosis in patients after radical resection of hepatocellular carcinoma: a single-center retrospective study"],"prefix":"10.3389","volume":"14","author":[{"given":"Junzhang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suosu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuntian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuhuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongde","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianrong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.09.016","article-title":"Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine","volume":"68","author":"Fujiwara","year":"2018","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2019.08.010","article-title":"Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients","volume":"166","author":"Tsilimigras","year":"2019","journal-title":"Surgery"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002889","article-title":"Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma","volume":"268","author":"Pinna","year":"2018","journal-title":"Ann Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.4334","article-title":"Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: A multicenter study from China","volume":"154","author":"Xu","year":"2019","journal-title":"JAMA Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.1245\/s10434-022-11454-y","article-title":"Clinical features of recurrence after hepatic resection for early-stage hepatocellular carcinoma and long-term survival outcomes of patients with recurrence: A multi-institutional analysis","volume":"29","author":"Yao","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000505093","article-title":"Comparison of partial hepatectomy and transarterial chemoembolization in intermediate-stage hepatocellular carcinoma: A systematic review and meta-analysis","volume":"9","author":"Labgaa","year":"2020","journal-title":"Liver Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29883","article-title":"Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies","volume":"68","author":"Hyun","year":"2018","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i20.5935","article-title":"Prognostic factors for hepatocellular carcinoma recurrence","volume":"20","author":"Colecchia","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.11464","article-title":"Hepatocellular carcinoma tumour burden score to stratify prognosis after resection","volume":"107","author":"Tsilimigras","year":"2020","journal-title":"Br J Surg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002064","article-title":"The tumor burden score: A new \u201cMetro-ticket\u201d Prognostic tool for colorectal liver metastases based on tumor size and number of tumors","volume":"267","author":"Sasaki","year":"2018","journal-title":"Ann Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/cancers13040747","article-title":"Synergistic impact of alpha-fetoprotein and tumor burden on long-term outcomes following curative-intent resection of hepatocellular carcinoma","volume":"13","author":"Tsilimigras","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7150\/jca.83779","article-title":"Sex differences in the impact of metabolic dysfunction-associated fatty liver disease on the of patients with hepatocellular carcinoma after radical resection","volume":"14","author":"Huang","year":"2023","journal-title":"J Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12885-021-07948-9","article-title":"Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods","volume":"21","author":"Kuo","year":"2021","journal-title":"BMC Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn-22-469","article-title":"A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights","volume":"12","author":"Xie","year":"2023","journal-title":"Hepatobil Surg Nutr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S289840","article-title":"Association of postoperative biomarker response with recurrence and survival in patients with hepatocellular carcinoma and high alpha-fetoprotein expressions (>400 ng\/ml)","volume":"8","author":"Liang","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy510","article-title":"Correction to: \u201cHepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Vogel","year":"2019","journal-title":"Ann Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/apt.16563","article-title":"Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma","volume":"54","author":"Harding-Theobald","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.01.014","article-title":"Advances in the early diagnosis of hepatocellular carcinoma","volume":"7","author":"Wang","year":"2020","journal-title":"Genes Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.7412","article-title":"Future of hepatocellular carcinoma incidence in the United States forecast through 2030","volume":"34","author":"Petrick","year":"2016","journal-title":"J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0253-3766.2019.10.001","article-title":"Liver cancer epidemiology in China, 2015","volume":"41","author":"An","year":"2019","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2022.01245","article-title":"Advances in the surgical treatment of liver cancer","volume":"16","author":"Maki","year":"2022","journal-title":"Biosci Trends"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma: A review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-017-3526-7","article-title":"Trends in the mortality of hepatocellular carcinoma in the United States","volume":"21","author":"Beal","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-021-06265-3","article-title":"Impact of tumor burden score on conditional survival after curative-intent resection for hepatocellular carcinoma: A multi-institutional analysis","volume":"45","author":"Elfadaly","year":"2021","journal-title":"World J Surg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2022.07.019","article-title":"Impact of tumor burden score on timing and patterns of recurrence after curative-intent resection of hepatocellular carcinoma","volume":"172","author":"Moazzam","year":"2022","journal-title":"Surgery"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26091","article-title":"Recurrence beyond the Milan criteria after curative-intent resection of hepatocellular carcinoma: A novel tumor-burden based prediction model","volume":"122","author":"Tsilimigras","year":"2020","journal-title":"J Surg Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-230108","article-title":"Preoperative albumin-alkaline phosphatase ratio affects the prognosis of patients undergoing hepatocellular carcinoma surgery","volume":"39","author":"Huang","year":"2023","journal-title":"Cancer Biomark"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.3390\/cancers14215292","article-title":"Modified albumin-bilirubin grade and alpha-fetoprotein score (mALF score) for predicting the prognosis of hepatocellular carcinoma after hepatectomy","volume":"14","author":"Kaibori","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12957-022-02792-y","article-title":"Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment","volume":"20","author":"Xiong","year":"2022","journal-title":"World J Surg Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.906778","article-title":"Epidemiological characteristics of primary liver cancer in mainland China from 2003 to 2020: A representative multicenter study","volume":"12","author":"Lin","year":"2022","journal-title":"Front Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.09.001","article-title":"Post hepatectomy liver failure (PHLF) - Recent advances in prevention and clinical management","volume":"47","author":"S\u00f8reide","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2022.11.008","article-title":"Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma","volume":"25","author":"Lima","year":"2023","journal-title":"HPB (Oxford)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1159\/000514031","article-title":"Preoperative Controlling Nutritional Status plus Tumor Burden Score for the Assessment of Prognosis after Curative Liver Resection for Hepatocellular Carcinoma","volume":"30","author":"Fukami","year":"2021","journal-title":"Med Princ Pract"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20472","article-title":"Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma","volume":"11","author":"Pawlik","year":"2005","journal-title":"Liver Transpl"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevOncog.2020034987","article-title":"Significance of the tumor microenvironment in liver cancer progression","volume":"25","author":"Muppala","year":"2020","journal-title":"Crit Rev Oncog"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.51821\/84.4.015","article-title":"Worldwide prevalence, genotype distribution and management of hepatitis C","volume":"84","author":"Guntipalli","year":"2021","journal-title":"Acta Gastroenterol Belg"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1359017\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T05:10:25Z","timestamp":1730437825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1359017\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":41,"alternative-id":["10.3389\/fonc.2024.1359017"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1359017","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"article-number":"1359017"}}